Androgenetic Alopecia
📧 Sign up to get email alerts when something new happens for Androgenetic Alopecia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-09-12Clinical Trial Update: AGA Biocellular Stem/Stromal Hair Regenerative Study [Phase 1, Phase 2]
The AGA Biocellular Stem/Stromal Hair Regenerative Study (Phase 1/Phase 2) conducted by Healeon Medical Inc. has been withdrawn. The trial r…
-
CLINICAL_TRIALS withdrawal · 2025-02-06Clinical Trial Update: Plasma Rich in Growth Factors (PRGF-Endoret)in the Treatment of Androgenetic Alopecia [NA]
This clinical trial evaluating Plasma Rich in Growth Factors (PRGF-Endoret) for androgenetic alopecia was withdrawn before completion, with …
-
CLINICAL_TRIALS withdrawal · 2025-01-27Clinical Trial Update: Hydraderm for Androgenic Alopecia [Phase 4]
A Phase 4 clinical trial of Hydraderm for androgenetic alopecia has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-10-15Clinical Trial Update: Clinical Study of Probiotic Treatment for Androgenetic Alopecia [Phase 3]
A Phase 3 clinical trial evaluating a probiotic treatment for androgenetic alopecia has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-01-24Clinical Trial Update: Minoxidil Dose Response Study in Females Identified Through IVD Testing as Non-Responders to 5% Topical Minoxidil [NA]
The trial NCT02486848 evaluating the dose response of minoxidil in women identified as non-responders to 5% topical minoxidil has been withd…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2016-09-02Clinical Trial Update: The Use of 5mg Finasteride Versus 200mg Spironolactone and Topical 5% Minoxidil in Treating Postmenopausal Female Androgenetic Alopecia [Phase 4]
Phase 4 trial evaluating finasteride vs spironolactone and topical minoxidil for postmenopausal female androgenetic alopecia has been withdr…